Common side effects include nausea, vomiting, diarrhea, and mild gastrointestinal discomfort
Es importante destacar que tirzepatida no est indicada para el tratamiento de la diabetes tipo 1 y no requiere ajuste de dosis en pacientes con insuficiencia renal, aunque se recomienda monitoreo cuidadoso si ocurren efectos gastrointestinales significativos
Srijithesh PR, Aghoram R, Goel A, Dhanya J
The question now is how stakeholders across the healthcare ecosystem will respond to this groundswell of consumer engagement, and whether they can seize the opportunity to improve outcomes for millions of Americans
Since the first release of these drugs, demand has grown by 75%, he said
GLP-1 agonists are not a replacement for antihypertensive therapy but may complement it